Abstract:BackgroundAdvances in antibody engineering provide strategies to construct recombinant antibody-like molecules with modified pharmacokinetic properties. Multermerization is one strategy that has been used to produce antibody-like molecules with two or more antigen binding sites. Multimerization enhances the functional affinity (avidity) and can be used to optimize size and pharmacokinetic properties. Most multimerization strategies involve genetically fusing or non-covalently linking antibody fragments using oligomerization domains. Recent studies have defined guidelines for producing antibody-like molecules with optimal tumor targeting properties, which require intermediates size (70–120 kDa) and bi- or tri-valency.ResultsWe described a highly modular antibody-engineering platform for rapidly constructing synthetic, trivalent single chain variable fragments (Tri-scFv) using the SpyCatcher/SpyTag protein ligase system. We used this platform to construct an anti-human epidermal growth factor receptor 3 (HER3) Tri-scFv. We generated the anti-HER3 Tri-scFv by genetically fusing a SpyCatcher to the C-terminus of an anti-HER3 scFv and ligating it to a synthetic Tri-SpyTag peptide. The anti-HER3 Tri-scFv bound recombinant HER3 with an apparent KD of 2.67 nM, which is approximately 12 times lower than the KD of monomeric anti-HER3 scFv (31.2 nM). Anti-HER3 Tri-scFv also bound endogenous cell surface expressed HER3 stronger than the monomer anti-HER3 scFv.ConclusionWe used the SpyTag/SpyCatcher protein ligase system to ligate anti-HER3 scFv fused to a SpyCatcher at its C-termini to a Tri-SpyTag to construct Tr-scFv. This system allowed the construction of a Tri-scFv with all the scFv antigen-binding sites pointed outwards. The anti-HER3 Tri-scFv bound recombinant and endogenously expressed HER3 with higher functional affinity (avidity) than the monomeric anti-HER3 scFv. The Tri-scFv had the size, valency, and functional affinity that are desired for therapeutic and imaging applications. Use of the SpyTag/SpyCatcher protein ligase system allows Tri-scFvs to be rapidly constructed in a simple, modular manner, which can be easily applied to scFvs or other antibody fragments targeting other antigens.

A recombinant single-chain trispecific antibody against three toxins and activity in the synchronization detection

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Preparation and Immunological Characteristics of Broad-Spectrum Antibodies Against Poly-Recombinant Toxins from Food-Borne Pathogenic Bacteria

Engineered domain-based assays to identify individual antibodies in oligoclonal combinations targeting the same protein.

Cnstruction,expression and activity analysis of ScFv against TTX

Identification of tetrodotoxin antigens and a monoclonal antibody

Selection and Identification of a DNA Aptamer That Mimics Saxitoxin in Antibody Binding

Expression and characterization of single-chain variable fragment antibody against staphylococcal enterotoxin A in Escherichia coli.

Construction of a Single Chain Variable Fragment Antibody Against Sulfonamides and Its Interaction with Sulfathiazole

Functional Recombinant Single-Chain Variable Fragment Antibody Against Agkistrodon Acutus Venom

Development of Antibody-Based Assays for Omega-Conotoxin Mviia

Cloning Sequence Analysis and Expression of ScFv Against Okadaic Acid

Production and Characterization of a Single-Chain Variable Fragment Antibody from a Site-Saturation Mutagenesis Library Derived from the Anti-Cry1a Monoclonal Antibody.

Expression of ScFv Genes Against Alpha Toxin of Clostridium Perfringens Type A

Domain-based assays of individual antibody concentrations in an oligoclonal combination targeting a single protein.

Production and Epitope Studying of Monoclonal Antibody Against IMPDH in SS2

Preparation and the Specificity of Monoclonal Antibody against Saxitoxin

Characterization of an Anti-Thioredoxin Monoclonal Antibody

A novel synthetic trivalent single chain variable fragment (tri-scFv) construction platform based on the SpyTag/SpyCatcher protein ligase system

Production and Characterization of Monoclonal Antibody Broadly Recognizing Cry1 Toxins by Use of Designed Polypeptide As Hapten